Literature DB >> 20592781

Oncology care in rural northern new England.

Ali Johnson1, Judy R Rees, Molly Schwenn, Bruce Riddle, Castine Verrill, Maria O Celaya, Dawn A Nicolaides, Sai Cherala, Melanie Feinberg, Ann Gray, Lisa Rutstein, Matthew S Katz, Johannes C Nunnink.   

Abstract

PURPOSE: A team from Maine, New Hampshire, and Vermont evaluated quality of care for breast and colon cancers in these predominantly rural states.
METHODS: Central cancer registry records from diagnosis years 2003 to 2004 in Maine, New Hampshire, and Vermont were aggregated. Patient residence was classified into three tiers (small rural, large rural, and urban) using Rural-Urban Commuting Area classification.
RESULTS: Among 6,134 women diagnosed with breast cancer, there were significant differences between rural and urban residents in age (P < .001), stage (P < .001), and tumor size (P = .006). Use of breast-conserving surgery was similar, but sentinel lymph node (SLN) dissection was more common in urban (44.1%) than in large rural (39.9%) and small rural (37.6%) areas. Patients who underwent SLN dissection were more likely to receive radiation therapy after lumpectomy than patients who underwent regional lymph node dissection without SLN (85.9% v 75.5%). However, there was no statistically significant association between the rates of postlumpectomy radiation therapy by residence. Among 2,848 patients with colon cancer, patient characteristics in rural and urban areas were similar, but there were differences in their subsequent surgical treatment (P < .001) and lymph node sampling (P = .079). Adjuvant chemotherapy for patients with stage III colon cancer was less frequent in rural (57.3%) than in urban areas (64.7%; P < .001).
CONCLUSION: Central cancer registry data, aggregated among three states, identified differences between rural and urban areas in care for patients with breast and colon cancers. To our knowledge, this is the first time residential category, cancer stage, and treatment data have been analyzed for multiple states using population-based data.

Entities:  

Year:  2010        PMID: 20592781      PMCID: PMC2835487          DOI: 10.1200/JOP.200015

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  14 in total

1.  Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04)

Authors:  E Mamounas; S Wieand; N Wolmark; H D Bear; J N Atkins; K Song; J Jones; H Rockette
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

2.  Breast and cervical carcinoma screening practices among women in rural and nonrural areas of the United States, 1998-1999.

Authors:  Steven S Coughlin; Trevor D Thompson; H Irene Hall; Pamela Logan; Robert J Uhler
Journal:  Cancer       Date:  2002-06-01       Impact factor: 6.860

3.  Collaborative Stage Data Collection System, Version 2: An introduction to site-specific factors: a new focus of abstracting.

Authors:  April Fritz
Journal:  J Registry Manag       Date:  2010

4.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17.

Authors:  B Fisher; J Dignam; N Wolmark; E Mamounas; J Costantino; W Poller; E R Fisher; D L Wickerham; M Deutsch; R Margolese; N Dimitrov; M Kavanah
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

Review 5.  Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999.

Authors:  C C Compton; L P Fielding; L J Burgart; B Conley; H S Cooper; S R Hamilton; M E Hammond; D E Henson; R V Hutter; R B Nagle; M L Nielsen; D J Sargent; C R Taylor; M Welton; C Willett
Journal:  Arch Pathol Lab Med       Date:  2000-07       Impact factor: 5.534

Review 6.  American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Authors:  Al B Benson; Deborah Schrag; Mark R Somerfield; Alfred M Cohen; Alvaro T Figueredo; Patrick J Flynn; Monika K Krzyzanowska; Jean Maroun; Pamela McAllister; Eric Van Cutsem; Melissa Brouwers; Manya Charette; Daniel G Haller
Journal:  J Clin Oncol       Date:  2004-06-15       Impact factor: 44.544

7.  How important are out-of-pocket costs to rural patients' cancer care decisions?

Authors:  Maria Mathews; Roy West; Sharon Buehler
Journal:  Can J Rural Med       Date:  2009

8.  Wait times for surgical and adjuvant radiation treatment of breast cancer in Canada and the United States: greater socioeconomic inequity in America.

Authors:  Kevin M Gorey; Isaac N Luginaah; Eric J Holowaty; Karen Y Fung; Caroline Hamm
Journal:  Clin Invest Med       Date:  2009-06-01       Impact factor: 0.825

9.  Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-09-19       Impact factor: 79.321

10.  Rural and urban differences in stage at diagnosis of colorectal and lung cancers.

Authors:  N C Campbell; A M Elliott; L Sharp; L D Ritchie; J Cassidy; J Little
Journal:  Br J Cancer       Date:  2001-04-06       Impact factor: 7.640

View more
  5 in total

1.  Commentary: "help the doctor"-the culture shift to 21st century care management.

Authors:  Stephen B Edge
Journal:  J Oncol Pract       Date:  2010-02-19       Impact factor: 3.840

2.  Preoperative carcinoembryonic antigen and prognosis of colorectal cancer. An independent prognostic factor still reliable.

Authors:  Giovanni Li Destri; Antonio Salvatore Rubino; Rosalia Latino; Fabio Giannone; Raffaele Lanteri; Beniamino Scilletta; Antonio Di Cataldo
Journal:  Int Surg       Date:  2015-04

Review 3.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Access to Care in Vermont: Factors Linked With Time to Chemotherapy for Women With Breast Cancer-A Retrospective Cohort Study.

Authors:  Ali Johnson; Leanne Shulman; Jennifer Kachajian; Brian L Sprague; Farrah Khan; Ted James; David Cranmer; Peter Young; Ruth Heimann
Journal:  J Oncol Pract       Date:  2016-08-30       Impact factor: 3.840

5.  Robotic Complete Mesocolic Excision with Central Vascular Ligation for Right Colon Cancer: Surgical Technique and Short-term Outcomes.

Authors:  C Ramachandra; Pavan Sugoor; Uday Karjol; Ravi Arjunan; Syed Altaf; Vijay Patil; Harish Kumar; G Beesanna; M Abhishek
Journal:  Indian J Surg Oncol       Date:  2020-08-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.